Bioterrorism
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Learning Objectives
After completion of the course you’ll be able to: Chapter 3: The Prospect of Domestic Bioterrorism
Chapter 5: Epidemiology of Bioterrorism
Chapter 7: Anthrax
Chapter 8: Smallpox
Chapter 9: Botulism
Chapter 10: Plague
Chapter 11: Tularemia
Chapter 12: Viral Hemorrhagic Fevers
Chapter 13: Ricin
Chapter 14: Nerve Agents
Chapter 15: Blister Agents
Chapter 16: Foodborne Illness
Chapter 17: Escherichia coli O157:H7
Chapter 18: Salmonellosis
Chapter 19: Cholera
Chapter 20: Shigellosis
Chapter 21: Brucellosis
Chapter 22: Typhoid Fever
Chapter 24: Injuries and Mass Trauma Events
Chapter 25: Bioterrorism Readiness Plan: A Template for Healthcare Facilities
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Learning Objectives To assess the effectiveness of the course material, we ask that you evaluate your achievement of each learning objective on a scale of A to D (A=excellent, B=good, C=fair, D=unsatisfactory). Please indicate your responses next to each learning objective and return it to us with your completed exam. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contents Outline | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. Bioterrorism as a Public Health Threat 2. The Threat of Biological Attack:
3. The Prospect of Domestic Bioterrorism Motivational
Factors
4. Biologic Terrorism–Responding to the Threat v Bioterrorism: How Prepared Are We? 5. Epidemiology of Bioterrorism
6. Medical Aspects of
Biological Terrorism
7. Anthrax v Questions and Answers About Anthrax
v Anthrax as a Biological Weapon
v
Update: Investigation of Bioterrorism-Related Anthrax and Interim
Guidelines for Exposure Management and Antimicrobial Therapy, October 2001
v Children and Anthrax: A Fact Sheet for Clinicians
v Anthrax Technical Information v Fact Sheet: Anthrax Information for Helath Care Providers v Drug Therapy
v Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of
Anthrax
v Additional Options for Preventive Treatment For Those Exposed to
Inhalational Anthrax
8. Smallpox v Smallpox Overview
v Smallpox Disease
v Smallpox Questions and Answers: The Disease and the Vaccine
9. Botulism v Facts About Botulism v Botulism–Technical Information v Frequently Asked Questions v Botulism in the United States
v Botulinum Toxin as a Biological Weapon–Medical and Public
Health Management
10. Plague v Facts About
Plague v Frequently Asked Questions (FAQ) About Plague v Introduction v History
v Plague as a Biological Warfare Agent v Epidemiology
v Clinical Manifestations v Diagnosis v Treatment v Prevention v Summary
11. Tularemia v Facts about Tularemia v Frequently Asked Questions (FAQ) About Tularemia v Tularemia as a Biological Weapon–Medical and Public Health
Management v Introduction v History and Potential Biological Weapon v Epidemiology
v Microbiology and Virulence Factors v Pathogenesis and Clinical Manifestations v Diagnosis v Vaccination
v Post-Exposure Antibiotic Recommendations
v Infection Control v Environmental Decontamination and Protection 12. Viral Hemorrhagic Fevers v Management of Patients with Suspected Viral Hemorrhagic Fever
v Hemorrhagic Fever Viruses as Biological Weapons
13. Ricin v Frequently Asked Questions (FAQs) About Ricin v Biotoxin Ricin 14. Nerve Agents v ToxFAQs™ for Nerve
Agents (GA, GB, GD, VX) v Facts About VX v Technical Information About Nerve Agents v Nerve Agent VX v Health Effects v Prehospital Management
v Emergency Department Management
15. Blister Agents
v Health Effects
v Prehospital Management
v Emergency Department Management v General Medical Management v Blister Agents Sulfur Mustard (H, HD, and HT)–Patient
Information Sheet v Blister Agent ...............................................................................
v Frequently Asked Consumer Questions About Food Safety and
Terrorism v Frequently Asked Questions v Technical Information 18. Salmonellosis v Frequently Asked Questions v Technical Information 19. Cholera v Frequently Asked Questions v Technical Information 20. Shigellosis v Frequently Asked Questions v Technical Information 21. Brucellosis v Frequently Asked Questions v Technical Information 22. Typhoid Fever v Frequently Asked Questions v Technical Information v CDC’s Roles in the Event of a Radiological Terrorist Event
24. Injuries and Mass Trauma Events v Coping With a Traumatic Event–Information for the Public v Coping With a Traumatic Event–Information for Health
Professionals v Burns
v Brain Injuries and Mass Trauma Event–Information for the
Public v Brain Injuries and Mass Trauma Events–Information for
Clinicians
v Chemical Agents: Facts About Personal Cleaning and Disposal of
Contaminated Clothing 25. Bioterrorism Readiness Plan: A Template for
Healthcare Facilities v Introduction v Section I: General Categorical
Recommendations for Any Suspected Bioterrorism Event
v Section II: Agent- Specific Recommendations B.
Botulism C.
Plague D. Smallpox 26. Mass Casualty Disaster Plan Checklist: A Template for Healthcare Facilities |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||